This report describes three children, aged eight to 11 years, with high-flow cerebral arteriovenous malformations who underwent interventional neuroradiological procedures involving glue (N-butyl cyanoacrylate) embolisation under general anaesthesia. The procedure was facilitated by relative hypotension induced by esmolol infusion and intravenous adenosine boluses. To allow controlled deposition of N-butyl cyanoacrylate into the arteriovenous malformations, glue injection was synchronised with the onset of adenosine-induced brief cardiac standstill. This resulted in satisfactory obliteration of the arteriovenous malformations nidus in all cases. The haemodynamic modulations, including the adenosine-induced brief cardiac standstill, was noted to not affect the BIS values in our patients. All patients had satisfactory obliteration of their arteriovenous malformations and had good neurological outcomes at one-year follow-up.
Endovascular treatment of cerebral arteriovenous malformations (AVM) has rapidly evolved and transformed neurosurgical and interventional radiological practice 1 . Anaesthetic management of these patients is complex and challenging. Glue embolisation (N-butyl cyanoacrylate) is now a well-established therapy for suitable AVMs. Highflow AVMs may have such high flow that the glue, although rapid setting, moves before setting in the feeding vessel or AVM. Potential risks of glue embolisation include passage into normal cortical vascular branches or draining veins with the risk of swelling and bleeding of the AVM causing neurological injury and pulmonary embolisation 2, 3 . The use of wedged microcatheters, simultaneous insertion of Guglielmi detachable coils, induced hypotension and transient flow arrest can all facilitate controlled deposition of glue in the feeding vessel and minimise adverse sequelae 4, 5 .
CASE HISTORIES
We report three children with high-flow AVMs who underwent glue embolisation in the interventional neuroradiology suite under general anaesthesia with adenosine-induced cardiac standstill to optimise glue deposition in the AVM. The demographic profile of the patients and procedural details are summarised in Table 1 . Two of the children had Spetzler-Martin grade V lesions and one a grade IV lesion, relatively contraindicating direct surgical approaches. Children were premedicated orally with midazolam (0.5 mg/kg), ranitidine and ondansetron. Intravenous dexamethasone, phenytoin and mannitol were also administered preoperatively to all the children. Monitoring included electrocardiography, invasive arterial blood pressure, central venous pressure (left internal jugular vein), capnography , core temperature and bispectral index (BIS, Aspect A-1000 EEG monitor; Aspect Medical System Inc., MA, USA). In view of the potential for complications arising from the planned brief induction of cardiac standstill with adenosine, an external defibrillator, transvenous pacing wires and appropriate resuscitation drugs were available. Anaesthesia was induced using intravenous (IV) fentanyl (2 µg/kg) and propofol (2 to 2.5 mg/kg bolus followed by 80 to 100 µg/kg/min infusion) and vecuronium (0.1 mg/kg). After endotracheal intubation and establishing intermittent positive pressure ventilation, anaesthesia was maintained using 50% N 2 O in O 2 and propofol infusion adjusted to achieve target BIS values of 50±5 and EtCO 2 of 35 to 40 mmHg. After vascular access for angiography was obtained, systemic heparinisation was induced (100 U/kg IV bolus, with additional flushes of the cannula with 1 U/ml in normal saline used during the procedure). At the onset of microcatheterisation, an FiO 2 of 100% O 2 was initiated. Induced relative hypotension was induced using esmolol, 0.5 mg/kg intravenous bolus, followed by an infusion at 100 to 150 µg/kg/h to maintain mean arterial blood pressure between 40 and 50 mmHg (i.e. 20 to 25% below the baseline values).
In one case, glue embolisation was preceded by insertion of a Guglielmi detachable coil into the AVM nidus to help minimise the risk of distal venous glue embolisation. When the interventionist indicated that all appropriate preparations for embolisation had been made, the esmolol infusion was withheld and escalating bolus doses of IV adenosine (i.e. 3, 6 then 12 mg) were injected through the jugular venous access to achieve maximum reduction in flow through the AVM without excessive reversal of flow. Thereafter, 12 mg adenosine was rapidly injected followed by a 10 ml normal saline flush to achieve 13 to 15 seconds of asystole, which was associated with systolic blood pressure recordings between 20 and 30 mmHg ( Figure 1 ). Glue injection was synchronised with the onset of adenosine-induced cardiac standstill with satisfactory filling of the AVM nidus ( Figure 2 ). At the end of the procedure, intravenous neostigmine (50 µg/kg) and glycopyrrolate (15 µg/kg) were administered for reversal of neuromuscular blockade. All three children were extubated after the completion of the procedure and were transferred to a high dependency unit for overnight observation. There were no adverse peri-procedural sequelae.
Post-embolisation diffusion magnetic resonance imaging revealed satisfactory obliteration of the AVM with the glue cast. All three children were well at follow-up after three, six and 12 months and did not require reembolisation.
DISCUSSIOn
AVMs may compromise neurological function by multiple mechanisms, including distortion of tissues with a mass effect, 'steal' compromising blood flow to surrounding tissues and rupture with the complications of intracerebral or subarachnoid haemorrhage. Subarachnoid haemorrhage can result in sympathetic stimulation, hydrocephalus, meningeal irritation, fluid and electrolyte disturbances and cerebral vasospasm 1 . Therapeutic embolisation encompasses a staged approach to the reduction and elimination of arteriovenous flow with its own risks but avoids the risks associated with open surgery 2 . Potential risks of embolisation include glue injection into the normal cortical vascular branches, passage into draining veins with the risk of swelling of or rupture and bleeding from the AVM and gluing of the catheter into the vessel being embolised 3, 6, 7 . Symptomatic pulmonary complications have been reported following acrylate glue injection, particularly when delivery systems without flow arrest were used in high flow vascular lesions 7, 8 . Induced hypotension is one of the most valuable means for reducing blood flow through the AVM 9 to allow retention of the glue at the site of injection. IV bolus doses of adenosine have been used in adults to facilitate safe, deep and complete glue deposition for embolisation of the main cerebral arterial feeders of AVMs 4,5 . There are few reports of the use of adenosineinduced cardiac standstill for this purpose in children. Hashimoto et al 5 studied dose-response characteristics of adenosine-induced ventricular asystole in five patients (four adults and one child) during endovascular embolisation of cerebral AVMs. This group recommended escalating doses of adenosine injections in the range of 0.24 to 1.76 mg/kg (6 to 90 mg) to determine the optimal dose for satisfactory filling of the AVM nidus. They also suggested that future studies are needed to more fully examine the risks of the induced transient cerebral hypoperfusion created by these interventions.
From the anaesthesiologist's point of view, use of rapid-onset, short-acting anaesthetic agents along with BIS monitoring facilitates accurate titration of depth of anaesthesia and also assists in early emergence from anaesthesia [9] [10] [11] . There are reports to suggest that BIS decreases when cerebral metabolism and function decrease due to hypothermia or hypotension. Other modalities have been used to detect perioperative cerebral insult such as motor evoked potentials, transcranial Doppler and jugular bulb venous HbO 2 saturation measurements [13] [14] [15] [16] . Hyashida et al 14 measured BIS and regional cerebral haemoglobin oxygen saturation (SrO 2 ) by nearinfrared spectroscopy in 10 children undergoing cardiac surgery. They noted 14 episodes of simultaneous reduction in BIS and S a O 2 in five children during acute hypotensive episodes, suggestive of cerebral hypoperfusion.
In the present series, our patients received a propofol-based general anaesthesia. For stepwise initiation and maintenance of controlled hypotension, we administered esmolol infusion as it does not abruptly affect cerebral autoregulatory mechanisms. This was augmented by adenosine 17 , a purine nucleoside. Adenosine is a ubiquitous endogenous substance. When exogenously administered, adenosine provides a number of potentially beneficial effects including neuromodulation, anti-nociception and cytoprotective actions. Adenosine has a rapid onset (<one minute) and brief duration of action (endogenous t½ 10 to 15 seconds) and a number of clinical applications including treatment of paroxysmal supraventricular tachycardia and inducing maximal coronary vasodilatation during pharmacologic stress testing 3, 18 . We found that the rapid but transient haemodynamic alterations caused by escalating bolus doses of adenosine facilitated satisfactory obliteration of the AVM nidus.
There was no effect on BIS values associated with these brief induced circulatory events. It is likely that the duration of flow arrest produced by the adenosine was shorter than the BIS monitor's time averaging epoch, but we take some reassurance that there was no change manifested that might have suggested interference with cerebral function. There is a delay of about 15 seconds before cerebral ischaemia produces changes in raw electroencephalogram 19 and our patients recovered normal sinus rhythm in less than 15 seconds.
Plaschke et al 18 studied haemodynamics, metabolic variables and cerebral function after cardiac arrest induced by high dose adenosine in patients undergoing endovascular repair of the thoracic aorta. They observed that after adenosineinduced cardiac arrest, changes in haemodynamic variables and electroencephalogram power spectra reversed completely within one and five minutes, respectively, without persistent brain dysfunction after stent graft implantation. Hashimoto et al reported transient atrial flutter in one out of five patients, when IV adenosine (0.25 to 0.35 mg/kg) in escalating doses of 10 to 20 mg was administered for AVM embolisation 5 . These changes spontaneously resolved after several minutes. Other potential adverse effects of adenosine under anaesthesia include tachyphylaxis to repeated bolus administration, skin flushing and bronchospasm. Although none of our patients had any adverse sequelae, this observational study of only three patients has too few patients to assert that that the technique is inherently 'safe'. Assessment of the place of this technique to facilitate glue obliteration of cerebral AVMs awaits further studies and comparison of the outcome associated with this technique with alternatives. If attempted, the technique of adenosine-induced cardiac standstill should be implemented with caution and appropriate monitoring and resuscitation equipment and drugs available (defibrillators, pacing devices, chronotropes).
In conclusion, adenosine-induced brief cardiac standstill was successfully used to facilitate endovascular N-butyl cyanoacrylate embolisation in three children with high-flow AVMs. All recovered well with no signs of neurological impairment. We noted that there was not even a transient change in BIS associated with the brief but dramatic fall in cerebral blood flow induced by the cardiac standstill.
